BioSpace News Archive

Business

Theriva Biologics to Host Conference Call and Webcast to Discuss Second Quarter 2023 Operational Highlights and Financial Results

Theriva Biologics announced that it plans to host a conference call on Tuesday, August 8, 2023, at 8:30 a.m. ET to discuss its financial results for the quarter ended June 30, 2023 and provide a corporate update.

August 1, 2023
·
2 min read
Business

Silk Road Medical Reports Second Quarter 2023 Financial Results

Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, reported financial results for the three months ended June 30, 2023.

August 1, 2023
·
6 min read
Biotech Bay

Cytokinetics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4) - August 01, 2023

Cytokinetics, Incorporated announced that on July 31, 2023 it granted stock options to purchase an aggregate of 60,200 shares of common stock to 3 new employees, whose employment commenced in July 2023, as a material inducement to their employment.

August 1, 2023
·
3 min read
Deals

Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Units

Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Units.

August 1, 2023
·
7 min read
Policy

Genesis MedTech announces FDA Breakthrough Device designation for the J-Valve™ Transfemoral System

Genesis MedTech, a leading medical device company, announced that its J-Valve™ Transfemoral System has been granted Breakthrough Device designation by the U.S. Food and Drug Administration.

August 1, 2023
·
3 min read
Drug Development

City of Hope scientists develop targeted chemotherapy able to kill all solid tumors in preclinical research

Researchers at City of Hope today published a new study explaining how they took a protein once thought to be too challenging for targeted therapy, proliferating cell nuclear antigen (PCNA), and developed a targeted chemotherapy that appears to annihilate all solid tumors in preclinical research.

August 1, 2023
·
5 min read
Braxia Scientific Reports Fiscal 2023 Financial Results

Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) (“Braxia Scientific”, or the “Company”), a medical research and telemedicine company with clinics providing innovative ketamine and psilocybin treatments for depression

August 1, 2023
·
8 min read
Business

Innoforce Strengthens Commercialization Leadership and Announces the Appointment of a New Chief Executive Officer

Zhejiang Innoforce Pharmaceuticals Co., Ltd., a CDMO company dedicated to providing one-stop-shop services to Advanced Therapy Medicinal Product customers and partners, announced Dr. Dewan Zeng as the new Chief Executive Officer, effective immediately.

August 1, 2023
·
2 min read
Biotech Beach

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 01, 2023

Acutus Medical, Inc. granted equity awards on August 1, 2023 that were approved by the Compensation Committee of its Board of Directors under Company’s 2022 Inducement Equity Incentive Plan, as a material inducement to employment to 3 individuals hired by Acutus in July 2023.

August 1, 2023
·
2 min read
Business

Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 8, 2023

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, announced that the Company will report second quarter financial results on Tuesday, August 8, 2023.

August 1, 2023
·
1 min read